Roche flashes new 16-week bispecific AMD data, setting eyes on pair of PhIII trials

Roche flashes new 16-week bispecific AMD data, setting eyes on pair of PhIII trials

Submitted by admin on May 6, 2020 - 12:17pm
Source: 
Endpoints
News Tags: 
Roche
clinical trials
bispecific antibodies
faricimab
wet age-related macular degeneration
Headline: 
Roche flashes new 16-week bispecific AMD data, setting eyes on pair of PhIII trials
snippet: 

While Roche awaits results from a pair of large Phase III trials, the Swiss pharma is touting another round of data from a smaller study on its wet macular degeneration (nAMD) bispecific antibody, faricimab.

Do Not Allow Advertisers to Use My Personal information